AI Article Synopsis
- The use of placebos in clinical practice is common among family doctors in Mexico, despite ongoing debates about their ethical implications.
- A study involving 307 family doctors revealed that 75% used placebos, with a notable preference for impure placebos like vitamins over pure placebos such as water.
- Family doctors often prescribed placebos for their psychological effects, particularly for patients with unexplained symptoms or chronic conditions, frequently responding to patient pressure.
Article Abstract
Introduction: The use of placebo has spread in clinical practice despite being controversial. In Mexico, the practice of family medicine is predominantly institutional and works with an essential medications list.
Objective: To determine the frequency and family doctor attitude regarding the use of placebos in clinical practice.
Method: Cross-sectional, observational, multicenter study of 307 family doctors with active practice in 27 states of the Mexican Republic. A questionnaire was used with sociodemographic data and consensus-developed questions about frequency of use and attitudes. For analysis, the square-chi test was used.
Results: 75% used placebos (95% CI=69.7-79.4%); 122 (39.7%) used pure placebos, mainly water (p < 0.05), and 220 (71.6%), impure placebos, mainly vitamins and laboratory tests. They were used more in patients with medically unexplained physical symptoms (178, 45.5%), including 122 (31.2%) "healthy worried" patients, or who had chronic conditions (40, 12.5%). Reasons for prescription: 249 (81%) for the psychological effect, when they showed benefit (176, 57%), even when it implied deceiving (78, 25%) or insufficient evidence of efficacy (57, 19%). The main reason was because of patient insistence.
Conclusions: More impure placebos were used, mainly in healthy worried patients and in those with chronic conditions.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.24875/GMM.19004667 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Surface Engineering Enhances Vanadium Carbide MXene-Based Nanoplatform Triggered by NIR-II for Cancer Theranostics.
Small
November 2024
Department of Nanomedicine & Shanghai Key Lab of Cell Engineering, Naval Medical University, Shanghai, 200433, P. R. China.
Article Synopsis
- Photothermal therapy for cancer has benefits like deep tissue penetration and non-invasive treatment, but creating effective agents for this therapy using NIR-II light is challenging.
- A new strategy involving surface modification of vanadium carbide MXene nanosheets (L-VC) improves their photothermal performance and adds the ability for magnetic resonance imaging through a MnO coating.
- The modified nanosheets (LVM-PEG) can effectively attack cancer cells in combination with NIR-II laser treatment, enhancing the immune response and providing a promising approach for cancer therapy using MXene-based materials.
A specific chiral HPLC method for lifitegrast and determination of enantiomeric impurity in drug substance, ophthalmic product and stressed samples.
J Pharm Biomed Anal
May 2024
Ankara University, Faculty of Pharmacy, Department of Analytical Chemistry, Ankara, Türkiye. Electronic address:
Lifitegrast is a lymphocyte function-associated antigen-1 (LFA-1) antagonist used to treat the indications and symptoms associated with dry eye disease (DED), one of the most common ocular surface diseases. Lifitegrast has a chiral center, and the S-enantiomer (S-Lif) is responsible for the therapeutic effects, while the R-enantiomer (R-Lif) lacks efficacy in the treatment of DED. Lifitegrast ophthalmic solution containing 5% lifitegrast was approved by the United States Food and Drug Administration (FDA) in July 2016 for the treatment of DED in patients 17 years of age and older.
View Article and Find Full Text PDF[Nocebo placebo, the hidden side of our treatments].
Rev Prat
October 2023
Psychiatre, anciennement anesthésiste ; fondateur du centre de référence de la douleur et de la migraine de l'hôpital Trousseau*, Paris, France ; responsable médical du 2e Plan national de lutte contre la douleur (2002-2005).
NOCEBO PLACEBO, THE HIDDEN SIDE OF OUR TREATMENTS. Our knowledge of the placebo effect and its opposite, the nocebo effect, has changed dramatically in the last 20 years. Any treatment activity induces this type of effect.
View Article and Find Full Text PDFThe Applicability of Chromatographic Retention Modeling on Chiral Stationary Phases in Reverse-Phase Mode: A Case Study for Ezetimibe and Its Impurities.
Int J Mol Sci
November 2023
Department of Pharmaceutical Industry and Management, George Emil Palade University of Medicine, Pharmacy, Science, and Technology of Targu Mures, 540142 Targu Mures, Romania.
Mechanistic modeling is useful for predicting and modulating selectivity even in early chromatographic method development. This approach is also in accordance with current analytical quality using design principles and is highly welcomed by the authorities. The aim of this study was to investigate the separation behavior of two different types of chiral stationary phases (CSPs) for the separation of ezetimibe and its related substances using the mechanistic retention modeling approach offered by the Drylab software (version 4.
View Article and Find Full Text PDFA methodological approach by capillary electrophoresis coupled to mass spectrometry via electrospray interface for the characterization of short synthetic peptides towards the conception of self-assembled nanotheranostic agents.
J Chromatogr A
January 2024
Institute of Chemistry for Life & Health Sciences (iCLeHS), Chimie ParisTech, PSL University, CNRS 8060, Paris 75005, France. Electronic address:
Nanostructures formed by the self-assembling peptide building blocks are attractive materials for the design of theranostic objects due to their intrinsic biocompatibility, accessible surface chemistry as well as cavitary morphology. Short peptide synthesis and modification are straightforward and give access to a great diversity of sequences, making them very versatile building blocks allowing for the design of thoroughly controlled self-assembled nanostructures. In this work, we developed a new CE-DAD-ESI-MS method to characterize short synthetic amphiphilic peptides in terms of exact sequence and purity level in the low 0.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!